Skip to main content
Year archive

NUFORMIX PLC — 2022 filings

All 34 regulatory filings released by NUFORMIX PLC (NFX) in 2022, sourced directly from the official regulator.

34 Filings
2022 Period
2022 filings (34)
Filing Released Lang
Nuformix hoping to 'initiate discussions with major pharma' in 2023
M&A Activity
2022-12-20 English
NXP004 Update
Regulatory Filings
2022-12-20 English
Half-year Report
Interim / Quarterly Report H1 2022
2022-12-13 English
Resignation of Auditor
Regulatory Filings
2022-12-05 English
Holding(s) in Company
Major Shareholding Notification
2022-11-16 English
Investor Webinar
Regulatory Filings
2022-11-04 English
NXP002 Update
Regulatory Filings
2022-09-23 English
Result of AGM
AGM Information
2022-08-25 English
Holding(s) in Company
Regulatory Filings
2022-08-19 English
NXP002 Completion of Tolerability Studies
Regulatory Filings
2022-08-10 English
Posting of Annual Report and Notice of AGM
AGM Information
2022-08-01 English
Board Changes
Board/Management Information
2022-07-28 English
Annual Results for the year ended 31 March 2022
Earnings Release FY 2022
2022-07-28 English
NXP002 data to be presented at 2022 ERS Congress
Regulatory Filings
2022-07-05 English
NXP004 Update
Regulatory Filings
2022-06-29 English
NXP002 Update
Regulatory Filings
2022-06-27 English
Holding(s) in Company
Major Shareholding Notification
2022-06-20 English
Directorate Change
Board/Management Information
2022-05-31 English
Corporate Update
Board/Management Information
2022-05-30 English
Second tranche of Lanstead subscription shares
Regulatory Filings
2022-04-12 English
Holding(s) in Company
Major Shareholding Notification
2022-04-11 English
Holding(s) in Company
Major Shareholding Notification
2022-04-08 English
Holding(s) in Company
Major Shareholding Notification
2022-04-07 English
Holding(s) in Company
Major Shareholding Notification
2022-04-05 English
NXP004 Patent
Share Issue/Capital Change
2022-03-28 English
Appointment of Dr Dan Gooding as Consultant
Regulatory Filings
2022-03-02 English
Change of Auditor
Audit Report / Information FY 2022
2022-03-01 English
Holding(s) in Company
Regulatory Filings
2022-02-14 English
Oxilio NXP-001 formulation development contract
Regulatory Filings
2022-02-08 English
Adviser Appointments
Regulatory Filings
2022-02-01 English
Director/PDMR Shareholding
Director's Dealing
2022-01-31 English
Result of General Meeting
AGM Information
2022-01-31 English
Posting of Circular and Notice of General Meeting
Regulatory Filings
2022-01-17 English
Director/PDMR Shareholding
Director's Dealing
2022-01-10 English